A Search for FDA Approved Drugs with Anti-ulcerative Effects: A computational Based Drug Repositioning Study

A Search for FDA Approved Drugs with Anti-ulcerative Effects: A computational Based Drug Repositioning Study

Peptic ulcer disease (PUD) remains a significant global health concern, with millions affected annually. Current treatments, such as proton pump inhibitors and H2 receptor antagonists, face limitations like drug resistance and side effects. Drug repurposing, utilizing FDA-approved drugs, offers a co...

Full description

Saved in:

Bibliographic Details
Main Author:	Abdulmajeed Yunusa1, Albashir Tahir1,2, Nura Abubakar1
Format:	Article
Language:	English
Published:	Hammer Head Production Limited 2025-05-01
Series:	Sokoto Journal of Medical Laboratory Science
Subjects:	peptic ulcer disease, drug repurposing, molecular docking, computational pharmacology.
Online Access:	https://sokjmls.com.ng/index.php/SJMLS/article/view/664
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Repositioning FDA-Approved Sulfonamide-Based Drugs as Potential Carbonic Anhydrase Inhibitors in <i>Trypanosoma cruzi</i>: Virtual Screening and In Vitro Studies
by: Eyra Ortiz-Pérez, et al.
Published: (2025-05-01)

In silico repurposing of FDA-approved drugs as multi-target inhibitors of glioblastoma
by: Ridwan Abiodun Salaam, et al.
Published: (2025-03-01)

Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
by: Saumya Choudhary, et al.
Published: (2025-07-01)

In Silico Study of FDA-Approved Drugs on <i>Leishmania infantum</i> CYP51, a Drug Repositioning Approach in Visceral Leishmaniasis
by: Juan Diego Guarimata, et al.
Published: (2024-11-01)

Pharmacological Treatment for Peptic Ulcer Bleeding
by: Dae Won Ma, et al.
Published: (2018-12-01)

Drug repurposing of fostamatinib against cancer via potential cytotoxicity and immune checkpoint regulation
by: Maoqiong Hu, et al.
Published: (2025-05-01)

Leveraging network pharmacology for drug discovery: Integrative approaches and emerging insights
by: Lu Li, et al.
Published: (2025-09-01)

Selective Cleaning Enhances Machine Learning Accuracy for Drug Repurposing: Multiscale Discovery of MDM2 Inhibitors
by: Mohammad Firdaus Akmal, et al.
Published: (2025-07-01)

Prioritizing FDA approved therapeutics for treating sepsis phenotypes: A network modeling approach based on neutrophil proteomics
by: Jordan C. Langston, et al.
Published: (2025-08-01)

Repurposing FDA-approved drugs to find a novel inhibitor of alpha-ketoglutarate-dependent dioxygenase FTO to treat esophageal cancer
by: Zeinab Mohammadi, et al.
Published: (2025-05-01)

VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01)

Repurposing antiviral drugs targeting the PARP-1 and HER2 pathways with multifaceted impacts through integrated network analysis and molecular mechanics
by: Uma Maheshwari Mugundan, et al.
Published: (2025-06-01)

In silico identification of potential HDAC3 inhibitors through machine learning, molecular docking, and molecular dynamics simulations for drug repurposing
by: Damilare P. Dosunmu, et al.
Published: (2025-12-01)

DIORS: Enhancing drug-target interaction prediction via structure and signature integrated-driven approach and discovering potential targeted molecules
by: Yiran Tang, et al.
Published: (2025-05-01)

Laparoscopic and open repair for perforated duodenal ulcer: single-center experience
by: Suren Agho Stepanyan, et al.
Published: (2018-06-01)

Risk of End-Stage Kidney Disease and Topiramate Use
by: Jean-Michel Halimi, et al.
Published: (2025-08-01)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01)

Risk of Peptic Ulcer Bleeding Associated with Infection, Nonsteroidal Anti-inflammatory Drugs, and Low-dose Aspirin Therapy in Peptic Ulcer Disease: A Case-control Study
by: Seung In Seo, et al.
Published: (2019-03-01)

Drug repurposing in traditional Chinese medicine: from empirical wisdom to modern therapeutic strategies
by: Yuan Wu, et al.
Published: (2025-07-01)

Alternative treatments to treat perforated peptic ulcer: a systematic review and network meta-analysis of randomized controlled trials
by: Paschalis Gavriilidis, et al.
Published: (2025-04-01)

Unveiling the Polypharmacological Potency of FDA-Approved Rebamipide for Alzheimer’s Disease
by: Israa J. Hakeem, et al.
Published: (2025-05-01)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

Eradication of Helicobacter pylori that contributes to hepatogenic ulcer is beneficial to the healing of hepatogenic ulcer
by: Guanen Qiao, et al.
Published: (2025-05-01)

Peptic Ulcer-related Stenosis
by: Cheol Woong Choi
Published: (2019-03-01)

Psychosocial and Behavioral Risk Factors of Peptic Ulcer Disease: A Case-Control Study
by: Kumayl Abbas Meghji, et al.
Published: (2025-07-01)

Identification and analysis of bHLH transcription factor family in red raspberry based on transcriptome sequencing
by: HE Zhimin1,2, ZHANG Junxin1,2, YU Liping1,2, HU Kang1,2, JI Fengqi1,2, HUANG Tiran1,2, YANG Mingfeng1,2*, MA Lanqing1,2
Published: (2024-09-01)

Correlation between abnormal leaf color phenomenon and endophytic bacteria of Loropetalum chinense var. rubrum
by: HUO Wenwen1,2, HOU Jiayi1,2, GAO Min1,2, XIA Wei1,2, LI Yanlin1,2, YU Xiaoying1,2, XU Lu1,2*
Published: (2024-10-01)

Helicobacter pylori-negative Peptic Ulcer
by: Ji Hyun Song, et al.
Published: (2017-09-01)

Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01)

Peptic Ulcer Disease
by: Seung Han Kim
Published: (2025-03-01)

Assessment of Dietary Pattern for Patients with Peptic Ulcer
by: Athra'a karim Hussein AL-Bahadli
Published: (2013-08-01)

Nonsteroidal Anti-Inflammatory Drug-Induced Peptic Ulcer Disease
by: Kyoung A Ko, et al.
Published: (2025-03-01)

中国花生国际贸易竞争力分析International trade competitiveness analysis of China′s peanut
by: 宋佳1,2，刘帅1,2 SONG Jia1,2, LIU Shuai1,2
Published: (2025-08-01)

Role of structure-based drug design (SBDD) in the repurposing and discovery of anti-viral leads against Monkeypox virus disease
by: Jihane Touhtouh, et al.
Published: (2025-07-01)

Bleeding gastroduodenal ulcers in patients without Helicobacter pylori infection and without exposure to non-steroidal anti-inflammatory drugs
by: Smolović Brigita, et al.
Published: (2014-01-01)

Laparoscopic Emergency Surgery for Perforated Peptic Ulcer: A Narrative Review
by: Jung Min Bae
Published: (2025-03-01)

The Effectiveness of Treatment of the Duodenum Peptic Ulcer in the Lviv Region (Retrospective Analysis)
by: Demydova A.
Published: (2018-12-01)

Prediction of antibiotic target proteins of streptococcus pyogenes using network pharmacology approach
by: Omobhude Fidelis Aluefua*, Abdulmajeed Yunusa, Ridwanu Zauro Abubakar
Published: (2025-05-01)

Prediction of complications of chronic duodenal ulcer using the method of determining the ratio of the level of melatonin receptors in the mucosa
by: Z. Kh. Osmanov, et al.
Published: (2020-11-01)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)